Abstract
Modakafusp Alfa (TAK-573), an Immunocytokine, Shows Clinical Activity in Patients with Relapsed/Refractory Multiple Myeloma; Updated Results from a First-in-Human Phase 1 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have